Document:

EX-10.3

 Exhibit 10.3 
 Employment Agreement 
 This Employment Agreement (the
“Agreement”) dated as of April 15, 2014 (the “Effective Date”), is made by and between Allison Transmission, Inc., a Delaware corporation (together with any successor thereto, the “Company”),
and David S. Graziosi (the “Executive”) (collectively referred to as the “Parties”). 

RECITALS 
  

	A.	It is the desire of the Company to assure itself of the services of the Executive by entering into this Agreement. 

 

	B.	The Executive and the Company mutually desire that the Executive provide services to the Company on the terms herein provided. 

AGREEMENT 

NOW, THEREFORE, in consideration of the foregoing and of the respective covenants and agreements set forth below the Parties hereto agree
as follows: 
  

	1.	Employment. 

  

	 	(a)	General. The Company shall employ the Executive and the Executive shall enter the employ of the Company, for the period set forth in Section 1(b), in
the position set forth in Section 1(c), and upon the other terms and conditions herein provided. 

  

	 	(b)	Employment Term. The initial term of employment under this Agreement (the “Initial Term”) shall be for the period beginning on the Effective
Date and ending on February 28, 2017, unless earlier terminated as provided in Section 3. On February 28, 2017 and each successive anniversary, the employment term hereunder shall automatically be extended for an additional
one-year period (“Extension Terms” and, collectively with the Initial Term, the “Term”) unless either Party gives notice of non-extension to the other no later than ninety (90) days prior to the then-applicable anniversary
of the Effective Date (in which case the Executive’s employment will terminate at the end of the then-applicable Term or any other date set by the Company in accordance with Section 3(b)) and subject to earlier termination as provided in
Section 3. 

  

	 	(c)	 Position and Duties. The Executive shall serve as the Executive Vice President, Chief Financial Officer, Treasurer and Assistant Secretary of
the Company and Allison Transmission Holdings, Inc. (“Parent”) with such customary responsibilities, duties and authority as may from time to time be assigned to the Executive by the Chief Executive Officer of the Company and Parent
or the Board of Directors of the Company, the Board of Directors of Parent or an authorized committee of either board (collectively, the “Board”). The Executive shall report to the Chief Executive Officer of the Company and

	 	
Parent and the Board. The Executive shall devote substantially all his working time and efforts to the business and affairs of the Company (which shall include service to its affiliates, if
applicable). The Executive agrees to observe and comply with the rules and policies of the Company as adopted by the Company from time to time. During the Term, it shall not be a violation of this Agreement for the Executive to (i) serve on
industry trade, civic or charitable boards or committees; (ii) deliver lectures or fulfill speaking engagements; (iii) manage his personal investments and affairs; and (iv) serve on the board of directors of two for-profit enterprises
with the Board’s prior consent, as long as such activities do not interfere with the performance of the Executive’s duties and responsibilities as an employee of the Company. 

 

	2.	Compensation and Related Matters. 

  

	 	(a)	Annual Base Salary. During the Term, the Executive shall receive a base salary at a rate of $575,000 per annum (the “Annual Base Salary”), which
shall be paid in accordance with the customary payroll practices of the Company. The Annual Base Salary shall be reviewed (and may be adjusted upward) at least annually by the Board. 

 

	 	(b)	Bonus. During the Term, the Executive shall be eligible to receive an annual performance-based bonus upon the achievement of certain performance goals, which
performance goals shall be determined by the Board in good faith after consultation with the Executive (the “Performance Bonus”). The Performance Bonus shall have a target equal to 115% of the Annual Base Salary (the “Target
Bonus”) and the Executive shall have the ability to earn more (up to 287.5% of Annual Base Salary) or less than the Target Bonus depending on the achievement of performance goals for the particular year, as follows:

  

	 	(i)	Over Performance: The amount of formulaic Performance Bonus earned by the Executive shall be increased by 6% of the Target Bonus for each percentage of
performance that exceeds the target performance goals for the year in question (rounded to the nearest percentage); provided, that the Performance Bonus earned in any one year shall not exceed 287.5% of Annual Base Salary. For example, if the
formulaic performance is 110% of target, the Executive’s formulaic payout is calculated at 184% of base salary (i.e., 115% of base salary for Target, plus 69% of base salary (6% x 115% x 10) = a bonus total of 184% of base salary).

  

	 	(ii)	Threshold Performance: The amount of formulaic Performance Bonus earned by the Executive shall be decreased by 5% of the Target Bonus for every percentage of
performance that is less than the target performance goals for the year in question. For example, if the formulaic performance is 85% of target, the Executive’s formulaic payout is calculated at 28.75% of base salary (i.e., 115% of base salary
for Target, less 5% x 115% x 15 = a net bonus total of 28.75% of base salary). 

  
 2 

	 	(iii)	The Performance Bonus for a particular year shall become due and payable only if the Executive remains employed with the Company as of the January 1 following such
year (the “Service Trigger Date”). If a Performance Bonus becomes due and payable for a particular year, then the Company shall pay such Performance Bonus to the Executive on the same day that the Company pays similar bonuses to
other executives of the Company, provided, however, that the Company shall in no event pay the Performance Bonus to the Executive after March 15 of the year following the year in which the applicable Service Trigger Date
occurs. Notwithstanding anything to the contrary in this Section 2(b), the Board may make reasonable adjustments, up or down, to the amount of Performance Bonus payable for any year to take into account extraordinary events, such as
acquisitions, dispositions and unusual or one time earnings fluctuations. 

  

	 	(c)	Long Term Incentive (LTI) Program. During the Term, the Executive will be eligible to receive long term incentive compensation in the form of equity compensation
or cash, as determined by the Board, consistent with the LTI Program provided to senior officers of the Company. Consistent with the target dollar value for the 2013-2015 LTI Program, the Executive’s target value for the 2014-2016 LTI Program
will be set at $920,000 (the “LTI Target”). Such LTI Program incentives will be established at the beginning of each three year period (i.e. 2015-2017, and 2016-2018) and may be adjusted by the Board, but in no case will it be
established at a target level below $920,000 during the Initial Term, with a minimum of 30% of the target level value comprised of restricted stock units or restricted stock. 

 

	 	(d)	Retention and Incentive Awards. During the Term, the Executive will receive the following cash retention and incentive awards (the “Retention
Bonuses”): 

  

	 	(i)	2014: $125,000, payable in the January 15, 2015 salaried payroll processing; 

 

	 	(ii)	2015: $250,000, payable in the January 15, 2016 salaried payroll processing; 

 

	 	(iii)	2016: $425,000, payable in the January 15, 2017 salaried payroll processing. 

 

	 	(e)	Restricted Stock Award. Separate from any LTI Program, as soon as reasonably practicable following the Effective Date, the Executive will receive 50,000 shares
of restricted common stock of Parent with the following vesting schedule: 

  

	 	(i)	17,500 shares vesting on January 31, 2015; 

  
 3 

	 	(ii)	17,500 shares vesting on January 31, 2016; and 

  

	 	(iii)	15,000 shares vesting on January 31, 2017. 

  

	 	(f)	Benefits. During the Term, the Executive shall be eligible to participate in employee benefit plans, programs and arrangements of the Company, as may be amended
from time to time, which are generally applicable to senior officers of the Company and its subsidiaries, which as of the time of this Agreement include the Company’s health and welfare plan and the Equity Incentive Plan of Parent (pursuant to
the terms to be set forth in a separate award agreement). If the group life insurance program of the Company does not permit coverage for the Executive as a multiple of annual salary comparable to that afforded other salaried and/or executive
employees (currently 10 times annual salary), the Company will reimburse the Executive for the cost of an additional term life policy for the difference, up to a maximum of $10,000 annually. 

 

	 	(g)	Vacation. During the Term, the Executive shall be entitled to paid vacation in accordance with the Company’s vacation policy, as it may be amended from time
to time; provided, however, the Executive shall be entitled to no less than twenty eight days of paid vacation each calendar year. Any vacation shall be taken at the reasonable and mutual convenience of the Company and the Executive.

  

	 	(h)	Expenses. During the Term, the Company shall reimburse the Executive for all reasonable travel and other business expenses incurred by him in the performance of
his duties to the Company in accordance with the Company’s expense reimbursement policy. 

  

	 	(i)	Key Person Insurance. At any time during the Term, the Company shall have the right to insure the life of the Executive for the Company’s sole benefit. The
Company shall have the right to determine the amount of insurance and the type of policy. The Executive shall reasonably cooperate with the Company in obtaining such insurance by submitting to physical examinations, by supplying all information
reasonably required by any insurance carrier, and by executing all necessary documents reasonably required by any insurance carrier. The Executive shall incur no financial obligation by executing any required document, and shall have no interest in
any such policy. 

  

	3.	Termination. 

 The
Executive’s employment hereunder may be terminated by the Company or the Executive, as applicable, without any breach of this Agreement only under the following circumstances: 

 

	 	(a)	Circumstances. 

  
 4 

	 	(i)	Death. The Executive’s employment hereunder shall terminate upon his death. 

 

	 	(ii)	Disability. If the Executive has incurred a Disability, as defined in Section 10(e), the Company may terminate the Executive’s employment.

  

	 	(iii)	Termination for Cause. The Company may terminate the Executive’s employment for Cause, as defined in Section 10(b). 

 

	 	(iv)	Termination without Cause. The Company may terminate the Executive’s employment without Cause. 

 

	 	(v)	Resignation for Good Reason. The Executive may resign his employment for Good Reason, as defined in Section 10(f). 

 

	 	(vi)	Resignation without Good Reason. The Executive may resign his employment without Good Reason. 

 

	 	(vii)	Non-extension of Term by the Company. The Company may give notice of non-extension to the Executive pursuant to Section 1(b).

  

	 	(viii)	Non-extension of Term by the Executive. The Executive may give notice of non-extension to the Company pursuant to Section 1(b) and the last day of
the applicable Term shall be the Executive’s Date of Termination and shall be considered the Executive’s “Retirement” hereunder. 

 

	 	(b)	Notice of Termination. Any termination of the Executive’s employment by the Company or by the Executive under this Section 3 (other than
termination pursuant to paragraph (a)(i)) shall be communicated by a written notice to the other Party hereto indicating the specific termination provision in this Agreement relied upon, setting forth in reasonable detail the facts and circumstances
claimed to provide a basis for termination of the Executive’s employment under the provision so indicated, and specifying a Date of Termination, as defined in Section 10(d), which shall be at least 60 days following the date of such notice
in the event of any termination of the Executive’s employment other than a Termination for Cause and at least 45 days following the date of such notice in the event of a Termination for Cause (a “Notice of Termination”). The
failure by the Company to set forth in the Notice of Termination any fact or circumstance which contributes to a showing of Cause shall not waive any right of the Company hereunder or preclude the Company from asserting such fact or circumstance in
enforcing the Company’s rights hereunder. Similarly, the failure by Executive to set forth in the Notice of Termination any fact or circumstance which contributes to a showing of Good Reason shall not waive any right of the Executive hereunder
or preclude the Executive from asserting such fact or circumstance in enforcing Executive’s rights hereunder. 

  
 5 

	 	(c)	Company Obligations upon Termination. Upon termination of the Executive’s employment pursuant to any of the circumstances listed in
Section 3(a), the Executive (or the Executive’s estate) shall be entitled to receive the sum of: (i) the portion of the Executive’s Annual Base Salary earned through the Date of Termination, but not yet paid to the
Executive; (ii) any bonus actually earned by the Executive in the year prior to the year in which the Date of Termination occurs, but not yet paid to the Executive; (iii) any expenses owed to the Executive under Section 2(h);
(iv) any accrued vacation pay owed to the Executive pursuant to Section 2(g), and (v) any amount accrued and arising from the Executive’s participation in, or benefits accrued under any employee benefit plans, programs or
arrangements under Section 2(f) (including, but not limited to, deferred compensation plans and vested company matching funds), which amounts shall be payable in accordance with the terms and conditions of such employee benefit plans,
programs or arrangements. (collectively, the “Company Arrangements”). For the avoidance of doubt, upon termination of the Executive’s employment for any reason, the Executive shall not be entitled to any other payments or
benefits (including Annual Base Salary) except as specifically provided for in this Section 3(c) or Section 4. 

  

	4.	Severance Payments. 

  

	 	(a)	Termination for Cause, or Resignation without Good Reason. If the Executive’s employment shall terminate pursuant to Section 3(a)(iii) for
Cause, or the Executive Resigns without Good Reason, the Executive shall not be entitled to any severance payment or benefits. 

  

	 	(b)	Termination upon Retirement. If the Executive’s employment shall terminate pursuant to Section 3(a)(viii) due to Executive’s Retirement
then, subject to the Executive signing, within forty-five (45) days following delivery to the Executive, which such delivery occurring within five (5) days from the Date of Termination, a release of claims against the Company in
substantially the form attached hereto as Exhibit A (the “Release”), and the Executive’s continued compliance with Sections 5 and 6, the Executive shall receive: 

 

	 	(i)	Pro-rated Vesting; and 

  

	 	(ii)	Continued Healthcare Coverage for twenty (24) months. 

  

	 	(c)	Death or Disability. If the Executive’s employment shall terminate as a result of Executive’s Death pursuant to Section 3(a)(i), or Disability
pursuant to Section 3(a)(ii) then, subject to the Executive (or his designated representative) signing, within forty-five (45) days following delivery to the Executive, which such delivery occurring within five (5) days from the Date
of Termination, the Release, and not revoking such Release, within the revocation period specified in the Release, and the Executive’s continued compliance with Sections 5 and 6, the Executive shall receive: 

 

	 	(i)	A lump sum payment equal to 2.0 times the Executive’s Annual Base Salary as of the Date of Termination, payable within sixty (60) days following the Date of
Termination; 

  
 6 

	 	(ii)	A lump sum payment equal to 2.0 times the Average Annual Bonus, payable within sixty (60) days following the Date of Termination; 

 

	 	(iii)	Pro-rata Vesting; and 

  

	 	(iv)	Continued Healthcare Coverage for sixty (60) months following the Date of Termination. 

 

	 	(d)	Termination without Cause, Resignation for Good Reason or upon Non-extension of Term by the Company. If the Executive’s employment shall terminate without
Cause pursuant to Section 3(a)(iv), shall terminate due to the Executive’s resignation for Good Reason pursuant to Section 3(a)(v) or pursuant to Section 3(a)(vii) due to Non-extension of the Term by the
Company then, subject to the Executive signing, within forty-five (45) days following delivery to the Executive, which such delivery occurring within five (5) days from the Date of Termination, the Release, and not revoking such Release,
within the revocation period specified in the Release, and the Executive’s continued compliance with Sections 5 and 6, the Executive shall receive: 

 

	 	(i)	A lump sum payment equal to 3.0 times the Annual Base Salary as of the Date of Termination, payable within sixty (60) days following the Date of Termination;

  

	 	(ii)	A lump sum payment equal to 3.0 times the Average Annual Bonus, payable within sixty (60) days following the Date of Termination; 

 

	 	(iii)	Full and immediate vesting of all unvested LTI Program awards granted to the Executive by the Company; provided, however, that any performance-based LTI Program awards
shall only vest and become payable subject to the attainment of the performance measures for the applicable performance period as provided under the terms of the applicable award agreement, which performance-based amount will vest and be paid to
Executive at the time originally scheduled to be paid to Executive under the terms of the applicable award agreement; 

  

	 	(iv)	A lump sum payment of the unpaid Retention and Incentive Awards, payable within sixty (60) days following the Date of Termination; and 

 

	 	(v)	Continued Healthcare Coverage for thirty six (36) months following the Date of Termination. 

If the payment of any amounts under Section 4 are delayed pending the Executive’s execution of the Release, as soon as
reasonably practicable following 

  
 7 

 
the date the Release becomes effective (but in no event later than, subject to Section 23, the earlier of (i) 30 days after the Release becomes effective, and
(ii) March 15th of the calendar year following
the calendar year in which the Release becomes effective), the Company will pay the Executive the amounts that would have otherwise been previously paid to the Executive under Section 4 prior to the execution of such Release, provided
that he has not revoked such Release. For the avoidance of doubt, no payments or benefits under Section 4 shall be made until the Executive has executed the Release and the required revocation period specified in the Release has expired;
provided, however, to the extent Pro-rata Vesting relates to restricted stock that is not subject to performance based vesting, then the Pro-rata Vesting with respect to such restricted stock shall occur without regard to the Release requirement.

  

	 	(e)	Survival. The expiration or termination of the Term shall not impair the rights or obligations of any Party hereto, which shall have accrued prior to such
expiration or termination 

  

	 	(f)	No Mitigation. Executive shall not be required to mitigate the amount of any payment provided for in this Section 4 by seeking other employment or
otherwise, nor shall the amount of any payment or benefit provided for in this Section 4 to be reduced by any compensation earned by the Executive as the result of employment by another employer, self-employment or by retirement benefits;
provided, however, that loans, advances or other amounts owed by the Executive to the Company may be offset by the Company against cash amounts payable to the Executive under this Section 4 at the time such cash amounts are payable to
the Executive under this Section 4. 

  

	 	(g)	Return of the Company’s Property. If the Executive’s employment is terminated for any reason, the Company shall have the right, at its option, to
require the Executive to vacate his offices prior to or on the effective date of termination and to cease all activities on the Company’s behalf. Upon the termination of his or her employment in any manner, as a condition to the
Executive’s receipt of any post-termination benefits described in this Agreement, the Executive shall immediately surrender to the Company all lists, books and records of, or in connection with, the Company’s business, and all other
property belonging to the Company, it being distinctly understood that all such lists, books and records, and other documents are the property of the Company. 

 

	 	(h)	Parachute Payments. 

  

	 	(i)	 It is the objective of this Agreement to maximize Executive’s Net After-Tax Benefit (as defined herein) if payments or benefits provided under
this Agreement are subject to excise tax under Section 4999 of the Code. Notwithstanding any other provisions of this Agreement, in the event that any payment or benefit by the Company or otherwise to or for the benefit of Executive, whether
paid or payable or distributed 

  
 8 

	 	
or distributable pursuant to the terms of this Agreement or otherwise (all such payments and benefits, including the payments and benefits under Section 4 hereof, being hereinafter referred
to as the “Total Payments”), would be subject (in whole or in part) to the excise tax imposed by Section 4999 of the Code (the “Excise Tax”), then the cash severance payments shall first be reduced, and the
non-cash severance payments shall thereafter be reduced, to the extent necessary so that no portion of the Total Payments shall be subject to the Excise Tax, but only if (i) the net amount of such Total Payments, as so reduced (and after
subtracting the net amount of federal, state and local income taxes on such reduced Total Payments and after taking into account the phase out of itemized deductions and personal exemptions attributable to such reduced Total Payments), is greater
than or equal to (ii) the net amount of such Total Payments without such reduction (but after subtracting the net amount of federal, state and local income taxes on such Total Payments and the amount of Excise Tax to which Executive would be
subject in respect of such unreduced Total Payments and after taking into account the phase out of itemized deductions and personal exemptions attributable to such unreduced Total Payments). 

 

	 	(ii)	The Total Payments shall be reduced by the Company in the following order: (i) reduction of any cash severance payments otherwise payable to Executive that are
exempt from Section 409A of the Code, (ii) reduction of any other cash payments or benefits otherwise payable to Executive that are exempt from Section 409A of the Code, but excluding any payments attributable to the acceleration of
vesting or payments with respect to any equity award with respect to the Parent’s common stock that is exempt from Section 409A of the Code, (iii) reduction of any other payments or benefits otherwise payable to Executive on a
pro-rata basis or such other manner that complies with Section 409A of the Code, but excluding any payments attributable to the acceleration of vesting and payments with respect to any equity award with respect to the Parent’s common stock
that are exempt from Section 409A of the Code, and (iv) reduction of any payments attributable to the acceleration of vesting or payments with respect to any other equity award with respect to the Parent’s common stock that are exempt
from Section 409A of the Code. 

  

	 	(iii)	 All determinations regarding the application of this Section 4(h) shall be made by an accounting firm with experience in performing calculations
regarding the applicability of Section 280G of the Code and the Excise Tax selected by the Company (“Independent Advisors”). For purposes of determining whether and the extent to which the Total Payments will be subject to the
Excise Tax, (i) no portion of the Total Payments the receipt or enjoyment of which Executive shall have waived at such time and in such manner as not to constitute a “payment” within the meaning of Section 280G(b) of the Code
shall be 

  
 9 

	 	
taken into account, (ii) no portion of the Total Payments shall be taken into account which, in the opinion of the Independent Advisors, does not constitute a “parachute payment”
within the meaning of Section 280G(b)(2) of the Code (including by reason of Section 280G(b)(4)(A) of the Code) and, in calculating the Excise Tax, no portion of such Total Payments shall be taken into account which, in the opinion of
Independent Advisors, constitutes reasonable compensation for services actually rendered, within the meaning of Section 280G(b)(4)(B) of the Code, in excess of the “base amount” (as defined in Section 280G(b)(3) of the Code)
allocable to such reasonable compensation, and (iii) the value of any non-cash benefit or any deferred payment or benefit included in the Total Payments shall be determined by the Independent Advisors in accordance with the principles of
Sections 280G(d)(3) and (4) of the Code. The costs of obtaining such determination and all related fees and expenses (including related fees and expenses incurred in any later audit) shall be borne by the Company. 

 

	 	(iv)	In the event it is later determined that a greater reduction in the Total Payments should have been made to implement the objective and intent of this
Section 4(h), the excess amount shall be returned immediately by the Executive to the Company, plus interest at a rate equal to 120% of the semi-annual applicable federal rate as in effect at the time of the Change in Control.

  

	5.	Competition. 

  

	 	(a)	The Executive shall not, at any time during the Term and for twenty four months after the Date of Termination, directly or indirectly engage in, have any equity
interest in, interview for a potential employment or consulting relationship with or manage or operate any person, firm, corporation, partnership or business (whether as director, officer, employee, agent, representative, partner, security holder,
consultant or otherwise) that engages in any business which competes with any portion of the Business (as defined below) of the Company anywhere in the world. Notwithstanding the foregoing, it shall not be a violation of this Section 5(a) for
the Executive to join a division or business line of a commercial enterprise, other than any Specified Entity, with multiple divisions or business lines if such division or business line is not competitive with the businesses of the Company and its
subsidiaries, provided that the Executive performs services solely for such non-competitive division or business line, and performs no functions on behalf of (and has no involvement with or direct or indirect responsibilities with respect to)
businesses competitive with the Business of the Company anywhere in the world. Nothing herein shall prohibit the Executive from being a passive owner of not more than 4.9% of the outstanding equity interest in any entity, other than any Specified
Entity, which is publicly traded, so long as the Executive has no active participation in the business of such entity. 

  
 10 

	 	(b)	The Executive shall not, at any time during the Term and for eighteen months after the Date of Termination, directly or indirectly, recruit or otherwise solicit or
induce any employee, customer, subscriber or supplier of the Company (i) to terminate its employment or arrangement with the Company, or (ii) to otherwise change its relationship with the Company. 

 

	 	(c)	In the event the terms of this Section 5 shall be determined by any court of competent jurisdiction to be unenforceable by reason of its extending for too
great a period of time or over too great a geographical area or by reason of its being too extensive in any other respect, it will be interpreted to extend only over the maximum period of time for which it may be enforceable, over the maximum
geographical area as to which it may be enforceable, or to the maximum extent in all other respects as to which it may be enforceable, all as determined by such court in such action. 

 

	 	(d)	As used in this Section 5, (i) the term “Company” shall include the Company, its subsidiaries, and Allison Transmission Holdings,
Inc., the parent of the Company, and (ii) the term “Business” shall include the manufacturing, development and sale of transmissions and the sale of replacement parts, “will-fit” parts, support equipment and
remanufactured transmissions for use in the vehicle aftermarket, as such business may be expanded or altered by the Company during the Term. 

  

	 	(e)	The Executive agrees, during the Term and following the Date of Termination, to refrain from disparaging the Company and its affiliates, including any of its services,
technologies or practices, or any of its directors, officers, agents, representatives or stockholders, either orally or in writing. The Company agrees, during the Term and following the Date of Termination, to refrain from disparaging the Executive;
provided, however, that the Company’s agreement to this non-disparagement clause shall be limited to official statements issued by the Company as an organization and statements of officers of the Company and members of the Board in their
official capacity as representatives of the Company. Nothing in this paragraph shall preclude the Executive, the Company, the members of the Board or officers of the Company from making truthful statements that are reasonably necessary to comply
with applicable law, regulation or legal process. 

  

	6.	Nondisclosure of Proprietary Information. 

  

	 	(a)	 Except in connection with the faithful performance of the Executive’s duties hereunder or pursuant to Section 6(c) and (e), the
Executive shall, in perpetuity, maintain in confidence and shall not directly, indirectly or otherwise, use, disseminate, disclose or publish, or use for his benefit or the benefit of any person, firm, corporation or other entity any confidential or
proprietary information or trade secrets of or relating to the Company (including, without limitation, business plans, business strategies and methods, acquisition targets, intellectual property in the form of patents,

  
 11 

	 	
trademarks and copyrights and applications therefor, ideas, inventions, works, discoveries, improvements, information, documents, formulae, practices, processes, methods, developments, source
code, modifications, technology, techniques, data, programs, other know-how or materials, owned, developed or possessed by the Company, whether in tangible or intangible form, information with respect to the Company’s operations, processes,
products, inventions, business practices, finances, principals, vendors, suppliers, customers, potential customers, marketing methods, costs, prices, contractual relationships, regulatory status, prospects and compensation paid to employees or other
terms of employment) (collectively, the “Confidential Information”), or deliver to any person, firm, corporation or other entity any document, record, notebook, computer program or similar repository of or containing any such
Confidential Information. The Parties hereby stipulate and agree that, as between them, any item of Confidential Information is important, material and confidential and affects the successful conduct of the businesses of the Company (and any
successor or assignee of the Company). Notwithstanding the foregoing, Confidential Information shall not include any information that has been published in a form generally available to the public prior to the date the Executive proposes to disclose
or use such information, provided, that such publishing of the Confidential Information shall not have resulted from the Executive directly or indirectly breaching his obligations under this Section 6(a) or any other similar provision by
which he is bound, or from any third-party breaching a provision similar to that found under this Section 6(a). For the purposes of the previous sentence, Confidential Information will not be deemed to have been published or otherwise disclosed
merely because individual portions of the information have been separately published, but only if all material features comprising such information have been published in combination. 

 

	 	(b)	Upon termination of the Executive’s employment with the Company for any reason, the Executive will promptly deliver to the Company all correspondence, drawings,
manuals, letters, notes, notebooks, reports, programs, plans, proposals, financial documents, or any other documents or property concerning the Company’s customers, business plans, marketing strategies, products, property or processes.

  

	 	(c)	The Executive may respond to a lawful and valid subpoena or other legal process but shall give the Company the earliest possible notice thereof, shall, as much in
advance of the return date as possible, make available to the Company and its counsel the documents and other information sought and shall assist such counsel at Company’s expense in resisting or otherwise responding to such process.

  

	 	(d)	As used in this Section 6 and Section 7, the term “Company” shall include the Company, its subsidiaries, and Allison
Transmission Holdings, Inc., the parent of the Company. 

  
 12 

	 	(e)	Nothing in this Agreement shall prohibit the Executive from (i) disclosing information and documents when required by law, subpoena or court order (subject to the
requirements of Section 6(c) above), (ii) disclosing information and documents to his attorney or tax adviser for the purpose of securing legal or tax advice, (iii) disclosing the Executive’s post-employment restrictions
in this Agreement in confidence to any potential new employer, or (iv) retaining, at any time, his personal correspondence, his personal contacts and documents related to his own personal benefits, entitlements and obligations.

  

	7.	Inventions. 

 All
rights to discoveries, inventions, improvements and innovations (including all data and records pertaining thereto) related to the business of the Company, whether or not patentable, copyrightable, registrable as a trademark, or reduced to writing,
that the Executive may discover, invent or originate during the Term, either alone or with others and whether or not during working hours or by the use of the facilities of the Company (“Inventions”), shall be the exclusive property
of the Company. The Executive shall promptly disclose all Inventions to the Company, shall execute at the request of the Company any assignments or other documents the Company may deem reasonably necessary to protect or perfect its rights therein,
and shall assist the Company, upon reasonable request and at the Company’s expense, in obtaining, defending and enforcing the Company’s rights therein. The Executive hereby appoints the Company as his
attorney-in-fact to execute on his behalf any assignments or other documents reasonably deemed necessary by the Company to protect or perfect its rights to any Inventions. 

 

	8.	Injunctive Relief. 

It is recognized and acknowledged by the Executive that a breach of the covenants contained in Sections 5, 6 and 7 will cause
irreparable damage to Company and its goodwill, the exact amount of which will be difficult or impossible to ascertain, and that the remedies at law for any such breach will be inadequate. Accordingly, the Executive agrees that in the event of a
breach of any of the covenants contained in Sections 5, 6 and 7, in addition to any other remedy which may be available at law or in equity, the Company will be entitled to specific performance and injunctive relief. 

 

	9.	Assignment and Successors. 

 The Company may assign its rights and obligations under this Agreement to any successor to all or substantially all of the business or the assets of the Company (by merger or otherwise), and may assign or
encumber this Agreement and its rights hereunder as security for indebtedness of the Company and its affiliates. This Agreement shall be binding upon and inure to the benefit of the Company, the Executive and their respective successors, assigns,
personnel and legal representatives, executors, administrators, heirs, distributees, devisees, and legatees, as applicable. None of the Executive’s rights or obligations may be assigned or transferred by the Executive, other than the
Executive’s rights to payments hereunder, which may be transferred only by will or operation of law. Notwithstanding the foregoing, the Executive shall be entitled, to the extent permitted under applicable law and applicable Company
Arrangements, to select and change a beneficiary or beneficiaries to receive compensation hereunder following his death by giving written notice thereof to the Company. 

  
 13 

	10.	Certain Definitions. 

  

	 	(a)	Average Annual Bonus. “Average Annual Bonus” shall mean the average of Executive’s three annual cash bonuses (referred to as the iComp Performance
Bonus) earned in the three fiscal years prior to the fiscal year in which the Date of Termination occurs. 

  

	 	(b)	Cause. The Company shall have “Cause” to terminate the Executive’s employment hereunder upon: 

 

	 	(i)	the Board’s determination that the Executive failed to substantially perform his duties as an employee of the Company (other than any such failure resulting from
the Executive’s Disability) that is reasonably expected to result in, or has resulted in, material economic damage to the Company or any of its affiliates (provided, that, to the extent such failure can be fully cured, the Company shall have
provided the Executive with at least 30 days’ notice of such failure and the Executive has not remedied the failure within the 30-day period); 

  

	 	(ii)	the Board’s determination that the Executive failed in any material respect to carry out or comply with any lawful and reasonable directive of the Board consistent
with the terms of this Agreement (provided, that, to the extent such failure can be fully cured, the Company shall have provided the Executive with at least 30 days’ notice of such failure and the Executive has not remedied the failure within
the 30-day period); 

  

	 	(iii)	the Executive’s conviction, plea of no contest, plea of nolo contendere, or imposition of unadjudicated probation for any felony or crime involving moral
turpitude; 

  

	 	(iv)	the Executive’s unlawful use (including being under the influence) or possession of illegal drugs on the Company’s (or any of its affiliate’s) premises
or while performing the Executive’s duties and responsibilities under this Agreement; or 

  

	 	(v)	the Executive’s commission of an act of fraud, embezzlement, misappropriation, willful misconduct, or breach of fiduciary duty against the Company or any of its
affiliates. 

  

	 	(c)	 Continued Healthcare Coverage. “Continued Healthcare Coverage” shall mean the Company’s reimbursement of Executive for, or direct
payment to the carrier for, the premium costs for the Executive and, where applicable, his spouse and dependents, for a period of time following the Date of Termination (the “Payment Period”), effective with the cessation of coverage as a

  
 14 

	 	
Company employee, under the same or a comparable Company group medical plan to the group medical plan that Executive was participating in as of the Date of Termination; provided that if the same
or comparable Company group medical plan is, at any time during such Payment Period, not available generally to senior officers of the Company, the Executive shall receive reimbursement for, or direct payment to the carrier for, the premium costs
under a group medical plan that is available to such senior officers of the Company; provided, however, if there is no opportunity to be included in a comparable Company group medical plan for all or a portion of the Payment Period, the Executive
may elect coverage under the same provisions as the 2014 Global Expatriate Personnel medical, vision, and dental plan during the remainder of the Payment Period; provided, further, if at any time the Company determines that its payment of any such
premiums on the Executive’s behalf or continued participation in any such plans would result in a violation of applicable law (including but not limited to the 2010 Patient Protection and Affordable Care Act, as amended by the 2010 Health Care
and Education Reconciliation Act), then in lieu of paying premiums pursuant to this clause, the Company shall pay the Executive on the last day of each remaining month of the Payment Period, a fully taxable cash payment equal to the COBRA premium
for such month, subject to applicable tax withholding, such payments to be made without regard to the Executive’s payment of healthcare premiums. 

  

	 	(d)	Date of Termination. “Date of Termination” shall mean (i) if the Executive’s employment is terminated by his death, the date of his death;
(ii) if the Executive’s employment is terminated pursuant to Section 3(a)(ii) – (vi) either the date indicated in the Notice of Termination or the date specified by the Company pursuant to Section 3(b),
whichever is earlier; (iii) if the Executive’s employment is terminated pursuant to Section 3(a)(vii) or Section 3(a)(viii), the expiration of the then-applicable Term. 

 

	 	(e)	Disability. “Disability” shall mean, the Executive’s inability to perform, with or without reasonable accommodation, the essential functions of
his position hereunder for a total of three months during any six-month period as a result of incapacity due to mental or physical illness as determined by a physician selected by the Company or its insurers and acceptable to the Executive or the
Executive’s legal representative, with such agreement as to acceptability not to be unreasonably withheld or delayed. Any refusal by the Executive to submit to a medical examination for the purpose of determining Disability shall be deemed to
constitute conclusive evidence of the Executive’s lack of a Disability. 

  

	 	(f)	 Good Reason. The Executive shall have “Good Reason” to resign his employment within ninety (90) days following (i) a
material diminution in the Executive’s authorities, duties, responsibilities or reporting relationship to the Chief Executive Officer of the Company and Parent, (ii) a material change in the geographic location at which the Executive must
perform services, which 

  
 15 

	 	
shall not include a relocation of the Executive’s principal place of employment to any location within a thirty (30) mile radius of the location from which the Executive served the
Company immediately prior to the relocation, (iii) a material diminution in the Executive’s Annual Base Salary from the Annual Base Salary in effect in the prior year, (iv) a material diminution in the Executive’s Target Bonus
from the Target Bonus in effect in the prior year, or (v) a material diminution in the Executive’s LTI Target. The Executive may not resign his employment for Good Reason unless the Executive provided the Company with at least 30 days
prior written notice of his intent to resign for Good Reason and the Company has not cured the breach within 30 days. 

  

	 	(g)	Pro-rated Vesting. “Pro-rated Vesting” shall mean pro-rated vesting of all unvested LTI Program awards granted to the Executive by the Company;
provided, however, that any performance-based LTI Program awards shall only vest and become payable subject to the attainment of the performance measures for the applicable performance period as provided under the terms of the applicable award
agreement, which performance-based amount will vest and be paid to Executive at the time originally scheduled to be paid to Executive under the terms of the applicable award agreement and the amount of vesting, in either case, shall be determined by
multiplying the total amount payable pursuant to the LTI Program award by a fraction, (i) the numerator of which is the number of days from the first day of the applicable LTI Program period through the Date of Termination, and (ii) the
denominator of which is the number of days from the first day of the applicable LTI Program period through the last day of the applicable LTI Program period. 

 

	 	(h)	Specified Entity. “Specified Entity” shall mean any of the following, including their affiliates: (i) ZF Friedrichshafen AG, (ii) Voith AG,
(iii) Eaton Corporation, (iv) Caterpillar, Inc. and (v) ArvinMeritor, Inc. 

  

	11.	Governing Law. 

This Agreement shall be governed, construed, interpreted and enforced in accordance with its express terms, and otherwise in accordance
with the substantive laws of the State of Indiana, without reference to the principles of conflicts of law of the State of Indiana or any other jurisdiction, and where applicable, the laws of the United States. 

 

	12.	Validity. 

 The
invalidity or unenforceability of any provision or provisions of this Agreement shall not affect the validity or enforceability of any other provision of this Agreement, which shall remain in full force and effect. 

  
 16 

	13.	Notices. 

 Any
notice, request, claim, demand, document and other communication hereunder to any Party shall be effective upon receipt (or refusal of receipt) and shall be in writing and delivered personally or sent by facsimile or certified or registered mail,
postage prepaid, as follows: 
  

	 	(a)	If to the Company: 

 Allison
Transmission, Inc. 
 Office of the General Counsel 
 One Allison Way 
 Indianapolis, IN 46222 

Facsimile: (317) 242-3254 
  

	 	(b)	If to the Executive: 

 David S.
Graziosi 
 or at any other address as any Party shall have specified by notice in writing to the other Party. 

 

	14.	Counterparts. 

This Agreement may be executed in several counterparts, each of which shall be deemed to be an original, but all of which together will
constitute one and the same Agreement. Signatures delivered by facsimile shall be deemed effective for all purposes. 
  

	15.	Entire Agreement. 

The terms of this Agreement are intended by the Parties to be the final expression of their agreement with respect to the employment of
the Executive by the Company and supersede all prior understandings and agreements, whether written or oral, including the Employment Agreement between the Company and the Executive dated November 1, 2007, as amended. The Parties further intend
that this Agreement shall constitute the complete and exclusive statement of their terms and that no extrinsic evidence whatsoever may be introduced in any judicial, administrative, or other legal proceeding to vary the terms of this Agreement.

  
 17 

	16.	Amendments; Waivers. 

 This Agreement may not be modified, amended, or terminated except by an instrument in writing, signed by the Executive and a duly authorized officer of Company. By an instrument in writing similarly
executed, the Executive or a duly authorized officer of the Company may waive compliance by the other Party or Parties with any specifically identified provision of this Agreement that such other Party was or is obligated to comply with or perform;
provided, however, that such waiver shall not operate as a waiver of, or estoppel with respect to, any other or subsequent failure. No failure to exercise and no delay in exercising any right, remedy, or power hereunder preclude any other or further
exercise of any other right, remedy, or power provided herein or by law or in equity. Except as otherwise set forth in this Agreement, the respective rights and obligations of the Parties under this Agreement shall survive any termination of the
Executive’s employment. 
  

	17.	No Inconsistent Actions. 

 The Parties hereto shall not voluntarily undertake or fail to undertake any action or course of action inconsistent with the provisions or essential intent of this Agreement. Furthermore, it is the intent
of the Parties hereto to act in a fair and reasonable manner with respect to the interpretation and application of the provisions of this Agreement. 
  

	18.	Construction. 

This Agreement shall be deemed drafted equally by both the Parties. Its language shall be construed as a whole and according to its fair
meaning. Any presumption or principle that the language is to be construed against any Party shall not apply. The headings in this Agreement are only for convenience and are not intended to affect construction or interpretation. Any references to
paragraphs, subparagraphs, sections or subsections are to those parts of this Agreement, unless the context clearly indicates to the contrary. Also, unless the context clearly indicates to the contrary, (a) the plural includes the singular and
the singular includes the plural; (b) “and” and “or” are each used both conjunctively and disjunctively; (c) “any,” “all,” “each,” or “every” means “any and all,” and
“each and every”; (d) “includes” and “including” are each “without limitation”; (e) “herein,” “hereof,” “hereunder” and other similar compounds of the word
“here” refer to the entire Agreement and not to any particular paragraph, subparagraph, section or subsection; and (f) all pronouns and any variations thereof shall be deemed to refer to the masculine, feminine, neuter, singular or
plural as the identity of the entities or persons referred to may require. 
  

	19.	Arbitration. 

 Any
controversy, claim or dispute arising out of or relating to this Agreement, shall be settled solely and exclusively by binding arbitration in Indianapolis, Indiana. Such arbitration shall be conducted in accordance with the then prevailing JAMS
Streamlined Arbitration Rules & Procedures, with the following exceptions if in conflict: (a) one arbitrator shall be chosen by JAMS; (b) each Party to the arbitration will pay its pro rata share of the expenses and fees of the
arbitrator, together with other expenses of the arbitration incurred or approved by the arbitrator; and (c) arbitration may proceed in the absence of any Party if written notice (pursuant to the

  
 18 

 
JAMS’ rules and regulations) of the proceedings has been given to such Party. Each Party shall bear its own attorneys fees and expenses. The Parties agree to abide by all decisions and
awards rendered in such proceedings. Such decisions and awards rendered by the arbitrator shall be final and conclusive. All such controversies, claims or disputes shall be settled in this manner in lieu of any action at law or equity; provided,
however, that nothing in this subsection shall be construed as precluding the bringing an action for injunctive relief as provided in Section 8. 
  

	20.	Enforcement. 

 If
any provision of this Agreement is held to be illegal, invalid or unenforceable under present or future laws effective during the term of this Agreement, such provision shall be fully severable; this Agreement shall be construed and enforced as if
such illegal, invalid or unenforceable provision had never comprised a portion of this Agreement; and the remaining provisions of this Agreement shall remain in full force and effect and shall not be affected by the illegal, invalid or unenforceable
provision or by its severance from this Agreement. Furthermore, in lieu of such illegal, invalid or unenforceable provision there shall be added automatically as part of this Agreement a provision as similar in terms to such illegal, invalid or
unenforceable provision as may be possible and be legal, valid and enforceable. 
  

	21.	Withholding. 

 The
Company shall be entitled to withhold from any amounts payable under this Agreement any federal, state, local or foreign withholding or other taxes or charges which the Company is required to withhold. The Company shall be entitled to rely on an
opinion of counsel if any questions as to the amount or requirement of withholding shall arise. 
  

	22.	Employee Acknowledgement. 

 The Executive acknowledges that he has read and understands this Agreement, is fully aware of its legal effect, has not acted in reliance upon any representations or promises made by the Company other
than those contained in writing herein, and has entered into this Agreement freely based on his own judgment. 
  

	23.	Section 409A. 

  

	 	(a)	General. The intent of the Parties is that the payments and benefits under this Agreement comply with or be exempt from Section 409A of the Internal Revenue
Code of 1986 (the “Code”), as amended, and the regulations and guidance promulgated thereunder (collectively, “Section 409A”) and, accordingly, to the maximum extent permitted, this Agreement shall be interpreted to
be in compliance therewith. 

  

	 	(b)	 Separation from Service. Notwithstanding anything in this Agreement to the contrary, any compensation or benefits payable under this Agreement
that is considered nonqualified deferred compensation under Section 409A and is designated under this Agreement as payable upon Executive’s termination of employment shall be payable only upon Executive’s “separation from
service” with the Company within the meaning of Section 409A (a “Separation from 

  
 19 

	 	
Service”) and, except as provided below, any such compensation or benefits described in Section 4 shall not be paid, or, in the case of installments, shall not commence payment,
until the thirtieth (60th) day following Executive’s Separation from Service (the “First Payment Date”). Any installment payments that would have been made to Executive during the sixtieth (60th) day period immediately following Executive’s Separation
from Service but for the preceding sentence shall be paid to Executive on the First Payment Date and the remaining payments shall be made as provided in this Agreement. 

 

	 	(c)	Specified Employee. Notwithstanding anything in this Agreement to the contrary, if Executive is deemed by the Company at the time of Executive’s Separation
from Service to be a “specified employee” for purposes of Section 409A, to the extent delayed commencement of any portion of the benefits to which Executive is entitled under this Agreement is required in order to avoid a prohibited
distribution under Section 409A, such portion of Executive’s benefits shall not be provided to Executive prior to the earlier of (i) the expiration of the six-month period measured from the date of Executive’s Separation from
Service with the Company or (ii) the date of Executive’s death. Upon the first business day following the expiration of the applicable Section 409A period, all payments deferred pursuant to the preceding sentence shall be paid in a
lump sum to Executive (or Executive’s estate or beneficiaries), and any remaining payments due to Executive under this Agreement shall be paid as otherwise provided herein. 

 

	 	(d)	Expense Reimbursements. To the extent that any reimbursements under this Agreement are subject to Section 409A, any such reimbursements payable to Executive
shall be paid to Executive no later than December 31 of the year following the year in which the expense was incurred; provided, that Executive submits Executive’s reimbursement request promptly following the date the expense is incurred,
the amount of expenses reimbursed in one year shall not affect the amount eligible for reimbursement in any subsequent year, other than medical expenses referred to in Section 105(b) of the Code, and Executive’s right to reimbursement
under this Agreement will not be subject to liquidation or exchange for another benefit. 

  

	 	(e)	Installments. Executive’s right to receive any installment payments under this Agreement, including without limitation any continuation salary payments that
are payable on Company payroll dates, shall be treated as a right to receive a series of separate payments and, accordingly, each such installment payment shall at all times be considered a separate and distinct payment as permitted under
Section 409A. Except as otherwise permitted under Section 409A, no payment hereunder shall be accelerated or deferred unless such acceleration or deferral would not result in additional tax or interest pursuant to Section 409A

  
 20 

	24.	Indemnification. 

The Company shall indemnify the Executive to the maximum extent permitted under the General Corporation Law of the State of Delaware for
acts taken within the scope of his employment. To the extent that the Company obtains coverage under a director and officer indemnification policy, the Executive will be entitled to such coverage on a basis that is no less favorable than the
coverage provided to any other officer or director of the Company. 
 [remainder of page intentionally left blank] 

  
 21 

 IN WITNESS WHEREOF, the Parties have executed this Agreement on the date and year first
above written. 
  

			
	COMPANY
		
	By:	 	 /s/ Eric C. Scroggins

		 	Name: Eric C. Scroggins
		 	Title:   Vice President, General Counsel and Secretary
	
	EXECUTIVE
		
	By:	 	 /s/ David S. Graziosi

		 	David S. Graziosi

 Exhibit A 

General Release and Waiver* 
 For and in consideration of the payments and other benefits due to David S. Graziosi (the “Executive”) pursuant to the Employment Agreement, dated as of March     ,
2014, by and between Allison Transmission, Inc. (the “Company”) and the Executive (the “Employment Agreement”), and for other good and valuable consideration, the Executive hereby agrees, for the Executive, the
Executive’s spouse and child or children (if any), the Executive’s heirs, beneficiaries, devisees, executors, administrators, attorneys, insurers, personal representatives, successors and assigns, to forever release, discharge and covenant
not to sue (the “Release”) the Company, or any of its divisions, affiliates, subsidiaries, parents, branches, predecessors, successors, assigns, and, with respect to such entities, their officers, directors, trustees, employees,
agents, shareholders, administrators, general or limited partners, representatives, attorneys and fiduciaries, past, present and future (the “Released Parties”) from any and all claims of any kind arising out of, or related to, his
employment with the Company, its affiliates and subsidiaries (collectively, with the Company, the “Affiliated Entities”), the Executive’s separation from employment with the Affiliated Entities, which the Executive now has or
may have against the Released Parties, whether known or unknown to the Executive, by reason of facts which have occurred on or prior to the date that the Executive has signed this Release. Such released claims include, without limitation, any and
all claims relating to the foregoing under federal, state or local laws pertaining to employment, including, without limitation, the Age Discrimination in Employment Act, Title VII of the Civil Rights Act of 1964, as amended, 42 U.S.C.
Section 2000e et. seq., the Fair Labor Standards Act, as amended, 29 U.S.C. Section 201 et. seq., the Americans with Disabilities Act, as amended, 42 U.S.C. Section 12101 et. seq. the
Reconstruction Era Civil Rights Act, as amended, 42 U.S.C. Section 1981 et. seq., the Rehabilitation Act of 1973, as amended, 29 U.S.C. Section 701 et. seq., the Family and Medical Leave Act of 1992, 29 U.S.C.
Section 2601 et. seq., and any and all state or local laws regarding employment discrimination and/or federal, state or local laws of any type or description regarding employment, including but not limited to any claims arising
from or derivative of the Executive’s employment with the Affiliated Entities, as well as any and all such claims under state contract or tort law. 
 The Executive has read this Release carefully, acknowledges that the Executive has been given at least twenty-one (21) days to consider all of its terms and has been advised to consult with an
attorney and any other advisors of the Executive’s choice prior to executing this Release, and the Executive fully understands that by signing below the Executive is voluntarily giving up any right which the Executive may have to sue or bring
any other claims against the Released Parties, including any rights and claims under the Age Discrimination in Employment Act. The Executive also understands that the Executive has a period of seven (7) days after signing this Release within
which to revoke his agreement, and that neither the Company nor any other person is obligated to make any payments or provide any other benefits to the Executive pursuant to the Employment Agreement until eight (8) days have passed since the
Executive’s signing of this Release without the Executive’s signature having been revoked other than any 
  

	*	 The Company may adjust the terms of this form release from time to time, including, without limitation, to reflect any changes in applicable laws.

  
 23 

 
accrued obligations or other benefits payable pursuant to the terms of the Company’s normal payroll practices or employee benefit plans. Finally, the Executive has not been forced or
pressured in any manner whatsoever to sign this Release, and the Executive agrees to all of its terms voluntarily. 

Notwithstanding anything else herein to the contrary, this Release shall not affect: (i) the Company’s obligations under any
compensation or employee benefit plan, program or arrangement (including, without limitation, obligations to the Executive under any stock option, stock award or agreements or obligations under any pension, deferred compensation or retention plan)
provided by the Affiliated Entities where the Executive’s compensation or benefits are intended to continue or the Executive is to be provided with compensation or benefits, in accordance with the express written terms of such plan, program or
arrangement, beyond the date of the Executive’s termination; or (ii) rights to indemnification or liability insurance coverage the Executive may have under the by-laws of the Company or applicable law. 

This Release is subject to Sections 11 and 19 of the Employment Agreement. This Release is final and binding and may not be
changed or modified except in a writing signed by both parties. 
  

					
	  
	 		 	  

	Date	 		 	David S. Graziosi
			
	  
	 		 	  

	Date	 		 	Allison Transmission, Inc.

  
 24exhibit_4-1.htm

Exhibit 4.1

 

 

	
A.

	
Designation. This series of preferred stock shall be designated "Series B Redeemable Preferred Stock" with par value of $0.001 per share (and referred to as the "Series B Redeemable Preferred Stock").

 

	
B.

	
Authorized Number. The number of authorized Shares constituting the Series B Redeemable Preferred Stock shall be 550.

 

	
C.

	
Dividends and Distributions.

 

(a)       The holders of the Series B Redeemable Preferred Stock shall be entitled to receive dividends at the rate of $6,750 per share (as adjusted for any stock dividends, combinations or splits with respect to such shares) per annum, respectively, payable out of funds legally available therefor. Such dividends shall be payable only when, as and if declared by the Board of Directors and shall accumulate quarterly commencing December 31, 2013, and shall be due and payable quarterly in arrears thereafter. Any dividend that accumulates but is unpaid shall be increased at a rate of 12% per annum, compounded quarterly, until such dividend is paid, and any dividend payment that is made without all accumulated dividends being paid shall be deemed to be payment for the most recent accumulated dividend or most recent accumulated and unpaid dividend.

 

No dividends (other than those payable solely in the Common Stock of the Corporation) shall be paid on any Common Stock of the Corporation during any fiscal year of the Corporation until dividends of $6,750 per share (as adjusted for any stock dividends, combinations or splits with respect to such shares or any increase in said amount because accumulated dividends were not paid) on the Series B Redeemable Preferred Stock shall have been paid or declared and set apart during that fiscal year and any prior year in which dividends accumulated but remain unpaid, and no dividends shall be paid on any share of Common Stock unless a dividend (including the amount of any dividends paid pursuant to the above provisions of this Section C) is paid with respect to all outstanding shares of Series B Redeemable Preferred Stock in an amount for each such share of Series B Redeemable Preferred Stock equal to or greater than the aggregate amount of such dividends for all shares of Common Stock into which each such share of Series B Redeemable Preferred Stock could then be converted.

 

Except as otherwise provided herein with respect to the Series B Redeemable Preferred Stock, no right shall accrue to holders of shares of Preferred Convertible Stock by reason of the fact that dividends on said shares are not declared in any prior year.

 

(b)       In the event the Corporation shall declare a distribution (other than any distribution described in Section D or F) payable in securities of other persons, evidences of indebtedness issued by the Corporation or other persons, assets (excluding cash dividends) or options or rights to purchase any such securities or evidences of indebtedness or any combination of the foregoing, then, in each such case the holders of the Series B Redeemable Preferred Stock shall be entitled to a proportionate share of any such distribution as thought the holders of the Series B Redeemable Preferred Stock were the holders of the number of shares of Common Stock of the Corporation into which their respective shares of Series B Redeemable Preferred Stock are convertible as of the record date fixed for the determination of the holders of Common Stock of the Corporation entitle to receive such distribution.

  

1

  

 

	
D. 

	
Preference on Liquidation.

 

(a)      In the event of any liquidation, dissolution or winding up of the Corporation, whether voluntary or involuntary, the holders of the Series B Redeemable Preferred Stock shall be entitled to receive, prior and in preference to any distribution or payment of any of the assets or surplus funds of the corporation to the holders of the Common Stock by reason of their ownership thereof, the amount of $1,000.00 per share (as adjusted for ay stock dividends, combinations or splits with respect to such shares), respectively, plus all accrued or declared but unpaid dividends on such share for each share of Series B Preferred stock then held by them. If upon the occurrence of such event, the assets and funds thus distributed among the holders of the Series B Redeemable Preferred Stock shall be insufficient to permit the payment to such holders of the full aforesaid preferential amount, then the entire assets and funds of the Corporation legally available for distribution shall be distributed ratably among the holders of the Series B Redeemable Preferred Stock in proportion to the preferential amount each such holder is otherwise entitled to receive.

 

(b)      After payment to the holders of the Common Stock and the Series B Redeemable Preferred Stock of the amounts set forth in Sections D.(a), the entire remaining assets and funds of the Corporation legally available for distribution, if any, shall be distributed among the holders of the Common Stock and the Series B Redeemable Preferred Stock in proportion to the shares of Common Stock then held by them and the shares of Common Stock which they then have the right to acquire upon conversion of the shares of Series B Redeemable Preferred Stock then held by them.

 

(c)      For purposes of this Section D, any Acquisition or Asset Transfer (as hereinafter defined), shall be deemed a liquidation, dissolution, or winding up of the Corporation and shall entitle the holders of Series B Redeemable Preferred Stock and Common Stock to receive, for each share of Series B Redeemable Preferred Stock and Common Stock, as the case may be, then held, at the closing of such Acquisition or Asset Transfer in cash, securities, or other property (valued as provided in Section D.(d) below) amounts as specified in Sections D.(a) and D.(b) above. For the purposes of this Section D: (i) “Acquisition” shall mean (A) any consolidation or merger of the Corporation with or into any other corporation or other entity orperson, or any other corporate reorganization, other than any such consolidation, merger or reorganizationin which the stsockholders of the Corporation immediately prior to such consolidation, merger or reorganization, continue to hold at least a majority of the voting power of the surviving entity (or, if the surviving entity is a wholly owned subsidiary, its parent) immediately after such consolidation, merger or reorganization; or (B) any transaction or series of related transactions to which the Corporation is a party in which in excess of 50% of the Corporation’s voting power is transferred; provided that an Acquisition shall not include any transactio or series of transactions principally for bona fide equity financing purposes in which cash is received by the Corporation or any successor or indebtedness of the Corporation is cancelled or converted or a combination thereof; and (ii) “Asset Transfer” shall mean a sale, lease, exclusive license or other disposition of all or substantially all of the assets of the Corporation.

  

2

  

 

(d)      Whenever the distribution provided for in the Section D shall be payable in securities or property other than cash, the value of such distribution shall be the fair market value of such securities or other property as determined in good faith by the Board of Directors.

 

	
E.

	
Voting Rights. Except as otherwise specified herein, holders of the Series B Redeemable Preferred Stock shall not have the right to vote.

 

	
F.

	
Redemption. The shares of the Series B Redeemable Preferred Stock may be redeemed at the option of the Corporation at any time prior to November 1, 2016, for an amount equal to the original purchase price of the Series B Convertible Preferred Shares plus all accrued but unpaid dividends thereon and thereafter at a price equal to the original purchase price of the Series B Convertible Preferred shares plus all accrued but unpaid dividends thereon and a redemption premium of 30% of the original purchase price.

 

	
  

	
(a)

	
Partial Redemption. In the event that fewer than all the outstanding shares of the Series B Redeemable Preferred Stock are to be redeemed, the number of shares to be redeemed shall be determined by the Board of Directors and the shares to be redeemed shall be determined by lot or prorata as may be determined by the Board of Directors or by any other method as may be determined by the Board of Directors in its sole discretion to be equitable.

 

	
  

	
(b)

	
Notice of Redemption. In the event the Corporation shall redeem shares of the Series B Redeemable Preferred Stock, notice of such redemption shall be given by first class mail, postage prepaid, mailed not less than 30 nor more than 60 days prior to the redemption date, to each holder of record of the shares to be redeemed, at such holder's address as the same appears on the stock records of the Corporation. Each such mailed notice shall state: (v) the redemption date; (w) the number of shares of the Series B Redeemable Preferred Stock to be redeemed and, if fewer than all the shares held by such holder are to be redeemed, the number of such shares to be redeemed from such holder; (x) the redemption price; (y) the place or places where certificates for such shares are to be surrendered for payment of the redemption price; and (z) that dividends on the shares to be redeemed will cease to accrue on such redemption date. No defect in the notice of redemption or in the mailing thereof shall affect the validity of the redemption proceedings, and the failure to give notice to any holder of shares of the Series B Redeemable Preferred Stock to be so redeemed shall not affect the validity of the notice given to the other holders of shares of the Series B Redeemable Preferred Stock to be so redeemed.

 

	
  

	
(c)

	
Dividends to Cease. Notice having been mailed as aforesaid, then, notwithstanding that the certificates evidencing the shares of the Series B Redeemable Preferred Stock shall not have been surrendered, from and after the redemption date (unless default shall be made by the Corporation in providing money for the payment of the redemption price) dividends on the shares of the B ConvertiblePreferred Stock so called for redemption shall cease to accrue, and said shares shall no longer be deemed to be outstanding, and all rights of the holders thereof as stockholders (including dividend and voting rights) or the Corporation (except the right to receive from the Corporation the redemption price) shall cease. Upon surrender, in accordance with said notice, of the certificates for any shares so redeemed (properly endorsed or assigned for transfer, if the Board of Directors shall so require and the notice shall so state), such shares shall be redeemed by the Corporation at the redemption price aforesaid. In case fewer than all the shares represented by any such certificate are redeemed, a new certificate shall be issued representing the unredeemed shares without cost to the holder thereof.

 

 

  

3

  

 

 

	
  

	
(d)

	
Shares to be Held in Treasury. Any shares of the Series B Redeemable Preferred Stock that shall at any time have been redeemed shall, after such redemption, in the discretion of the Board of Directors of the Corporation, be (x) held in treasury or (y) resume the status of authorized but unissued shares of preferred stock, without designation as to series, until such shares are once more designated as part of a particular series by the Board of Directors.

 

	
G.

	
Conversion. The holders of the Series B Redeemable Preferred Stock shall have conversion rights as follows (the “Conversion Rights”):

 

	
  

	
(a)

	
Right to Convert. After November 1, 2016, but not before, each share of Series B Redeemable Preferred Stock shall be convertible, at the option of the holder thereof, and on or prior to the fifth day prior to the Redemption Date, if any, occurring after said November 1, 2016, as may have been fixed in any Redemption Notice with respect to such share of Series B Redeemable Preferred Stock, at the office of the Corporation or any transfer agent for such stock, into such number of fully paid and non-assessable shares of Common Stock as is determined by dividing $100,000.00 by 120% of the closing bid price of the Corporation’s Common Stock on November 1, 2013 (the “Series B Conversion Price”). Such initial Series B Conversion Price shall be adjusted as hereinafter provided.

 

	
  

	
(b)

	
Mechanics of Conversion. A holder of any share of Series B Redeemable Preferred Stock may exercise the Conversion Right of such share by surrendering the certificate therefor, duly endorsed, at the office of the Corporation or of any transfer agent for the Series B Redeemable Preferred Stock, together with a written notice to the Corporation which shall state: (A) that such holder elects to convert the same; and (B) the number of shares of Series B Redeemable Preferred Stock being converted. Thereupon the Corporation shall promptly issue and deliver to the holder of such shares a certificate or certificates for the number of whole shares of Common Stock to which such holder shall be entitled. In lieu of any fractional shares to which the holder would otherwise be entitled, the Corporation shall issue an additional share such that no fractional shares of Common Stock shall be issued. If the certificate evidencing the Series B Redeemable Preferred Stock being converted shall also evidence shares of Series B Redeemable Preferred Stock not being converted, then the Corporation shall also deliver to the holder of such certificate a new stock certificate evidencing the Series B Redeemable Preferred Stock not converted. The conversion of any shares of Series B Redeemable Preferred Stock shall be deemed to have been made immediately prior to the close of business on the date that the shares of Series B Redeemable Preferred Stock to be converted are surrendered to the Corporation, and the person or persons entitled to receive the shares of Common Stock issuable upon such conversion shall be treated for all purposes as the record holder or holders of such shares of Common Stock on such date.

 

	
  

	
(c)

	
Adjustments to Series B Conversion Price for Certain Diluting Issuances.

 

	
  

	
(i) Special Definitions. For purposes of this Section G.(c), the following definitions shall apply:

  

4

  

	
  

	
(1)

	
“Options” shall mean rights, options, or warrants to subscribe for, purchase or otherwise acquire Common Stock, Series B Redeemable Preferred Stock, or Convertible Securities (defined below).

 

	
  

	
(2)

	
“Original Issue Date” shall mean the date on which a share of Series B Redeemable Preferred Stock was first issued.

 

	
  

	
(3)

	
“Convertible Securities “shall mean any evidences of indebtedness, shares (other than Common Stock and Series B Redeemable Preferred Stock) or other securities convertible into or exchangeable for Common Stock.

 

	
  

	
(4)

	
“Additional Shares of Common Stock” shall mean all shares of Common Stock issued (or, pursuant to Section G.(c)(iii), deemed to be issued) by the Corporation after the Original Issue Date, other than shares of Common Stock issuable or issued:

 

	
  

	
(A)

	
upon conversion of shares of Series B Redeemable Preferred Stock;

 

	
  

	
(B)

	
to officers, directors or employees of, are consultants to, the Corporation pursuant to stock option or stock purchase plans or agreements but not exceeding 500,000 shares of Common Stock (not of any repurchases of such shares or cancellations or expirations of options), subject to adjustment for all subdivisions and combinations;

 

	
  

	
(C)

	
as a dividend or distribution on Series B Redeemable Preferred Stock;

 

	
  

	
(D)

	
upon exercise or conversion of options or warrants outstanding as of the Original Issue Date; or

 

	
  

	
(E)

	
for which adjustment of the Series B Conversion Price is made pursuant to Section G.(d)

 

	 	
(ii)

	
No Adjustment of Series B Conversion Price. Any provision herein to the contrary not withstanding, no adjustment in the Series B Conversion Price for a series of Preferred Stock shall be made in respect of the issuance of Additional Shares of Common Stock unless the consideration per share (determined pursuant to Section G.(c)(v) hereof) for an Additional Share of Common Stock issued or deemed to be issued by the Corporation is less than the Series B Conversion Price for such series of Preferred Stock in effect on the date of, and immediately prior to, such issue.

 

	 	
(iii)

	
Deemed Issue of Additional Shares of Common Stock. In the event the Corporation at any time or from time to time after the Original Issue Date shall issue any Options or Convertible Securities or shall fix a record date for the determination of holders of any class of securities then entitled to receive any such Options or Convertible Securities, then the maximum number of shares (as set forth in the instrument relating thereto without regard to any provisions contained therein designed to protect against dilution) of Common Stock issuable upon the exercise of such Options or, in the case of Convertible Securities and Options for Convertible Securities or for Series B Redeemable Preferred Stock, the conversion or exchange of such Convertible Securities or Series B Redeemable Preferred Stock shall be deemed to be Additional Shares of Common Stock issued as of the time of such issue or, in case such a record date shall have been fixed, as of the close of business on such record date, provided that in any such case in which Additional Shares of Common Stock are deemed to be issued:

  

5

  

 

	
  

	
(1)

	
no further adjustments in the Series B Conversion Price shall be made upon the subsequent issue of such Convertible Securities, or Series B Redeemable Preferred Stock or shares of Common Stock upon the exercise of such Options or conversion or exchange of such Convertible Securities or Series B Redeemable Preferred Stock;

 

	
  

	
(2)

	
if such Options or Convertible Securities by their terms provide, with the passage of time or otherwise, for any increase or decrease in the consideration payable to the Corporation, or decrease or increase in the number of shares of Common Stock the number of shares issuable, upon the exercise, conversion or exchange thereof, the Series B Conversion Price computed upon the original issue thereof (or upon the occurrence of a record date with respect thereto), and any subsequent adjustments based thereon, shall, upon any such increase or decrease becoming effective, be recomputed to reflect such increase or decrease insofar as it affects such Options or the rights of conversion or exchange under such Convertible Securities (provided, however, that no such adjustment of the Series B Convertible Conversion Price shall affect Common Stock previously issued upon conversion of Series B Redeemable Preferred Stock);

 

	
  

	
(3)

	
upon the expiration of any such Options or any rights of conversion or exchange under such Convertible Securities which shall not have been exercised, the Series B Convertible Conversion Price computed upon the original issue thereof (or upon the occurrence of a record date with respect thereto), and any subsequent adjustments based thereon, shall, upon such expiration, be recomputed as if:

 

	 	
(A)

	
in the case of Convertible Securities or Options for Common Stock the only Additional Shares of Common Stock issued were the shares of Common Stock, if any, actually issued upon the exercise of such Options or the conversion or exchange of such Convertible Securities and the consideration received therefore was the consideration actually received by the Corporation for the issue of all such Options, whether or not exercised, plus the consideration actually received by the Corporation upon such exercise, or for the issue of all such Convertible Securities which were actually converted or exchanged, plus the additional consideration, if any, actually received by the Corporation upon such conversion or exchange and

 

	
  

	
(B)

	
in the case of Options for Convertible Securities or Series B Redeemable Preferred Stock only the Convertible Securities or Series B Redeemable Preferred Stock, if any, actually issued upon the conversion thereof were issued at the time of issue of such Options, and exercise thereof were issued at the time of issue of such Options, and the consideration received by the Corporation for the Additional Shares of Common Stock deemed to have been then issued was the consideration actually received by the Corporation for the issue of all such Options, whether or not exercised, plus the consideration deemed to have been received by the Corporation (determined pursuant to Section G.(c)) upon the issue of the Convertible Securities or Series B Redeemable Preferred Stock with respect to which such Options were actually exercised;

  

6

  

 

	
  

	
(4)

	
no readjustment pursuant to clause (2) or (3) above shall have the effect of increasing the Series B Conversion Price to an amount which exceeds the lower of (a) the Series B Conversion Price on the original adjustment date, or (b) the Series B Conversion Price that would have resulted from any issuance of Additional Shares of Common Stock between the original adjustment date and such readjustment date;

 

	
  

	
(5)

	
in the case of any Options which expire by their terms not more than 30 days after the date of issue thereof, no adjustment of the Series B Conversion Price shall be made until the expiration or exercise of all such Options, where upon such adjustment shall be made in the same manner provided in clause (3) above.

 

	 	
 iv) 

	
(Adjustment of Series B Conversion Price Upon Issuance of Additional Shares of Common Stock.

 

In the event the Corporation, at any time after the Original Issue Date shall issue Additional Shares of Common Stock (including Additional Shares of Common Stock deemed to be issued pursuant to Section G.(c)(iii) without consideration or for a consideration per share less than the Series B Conversion Price in effect on the date of and immediately prior to such issue, then and in such event, the Series B Conversion Price shall be reduced, concurrently with such issue, to a price (calculated to the nearest cent) determined by multiplying such Series B Conversion Price by a fraction, the numerator of which shall be the number of shares of Common Stock outstanding immediately prior to such issue plus the number of shares of Common Stock which the aggregate consideration received by the Corporation for the total number of Additional Shares of Common Stock so issued would purchase at such Series B Conversion Price in effect immediately prior to such issuance, and the denominator of which shall be the number of shares of Common Stock outstanding immediately prior to such issue plus the number of such Additional Shares of Common Stock so issued. For the purpose of the above calculation, the number of shares of Common Stock outstanding immediately prior to such issue shall be calculated on a fully diluted basis, as if all shares of Series B Redeemable Preferred Stock and all Convertible Securities had been fully converted into shares of Common Stock immediately prior to such issuance and any outstanding warrants, options or other rights for the purchase of shares of stock or convertible securities had been fully exercised immediately prior to such issuance (and the resulting securities fully converted into shares of Common Stock, if so convertible) as of such date, but not including in such calculation any additional shares of Common Stock issuable with respect to shares of Series B Redeemable Preferred Stock, Convertible Securities, or outstanding options, warrants or other rights for the purchase of stock or convertible securities, solely as a result of the adjustment of the respective Series B Conversion Prices (or other conversion ratios) resulting from the issuance of Additional Shares of Common Stock causing the adjustment in question.

 

	 	
(iv)

	
Determination of Consideration.

 

For purposes of this Section G.(c), the consideration received by the Corporation for the issue of any Additional Shares of Common Stock shall be computed as follows:

 

	 	
(1)

	
Cash and Property. Such consideration shall:

  

7

  

 

	
  

	
(A)

	
insofar, as it consists of cash, be computed at the aggregate amount of cash received by the Corporation excluding amounts paid or payable for accrued interest or accrued dividends;

 

	
  

	
(B)

	
insofar as it consists of property other than cash, be computed at the fair value thereof at the time of such issue, as determined in good faith by the Board of Directors; and

 

	
  

	
(C)

	
in the event Additional Shares of Common Stock are issued together with other shares or securities or other assets of the Corporation for consideration which covers both, be the proportion of such consideration so received, computed as provided in clauses (A) and (B) above, as determined in good faith by the Board of Directors.

 

	 	
(2) 

	
Options and Convertible Securities. The consideration per share received by the Corporation for Additional Shares of Common Stock deemed to have been issued pursuant to Section G.(c)(iii), relating to Options and Convertible Securities shall be determined by dividing:

 

	
  

	
(A)

	
the total amount, if any, received or receivable by the Corporation as consideration for the issue of such Options or Convertible Securities, plus the minimum aggregate amount of additional considerations (as set forth in the instruments relating thereto, without regard to any provision contained therein designed to protect against dilution) payable to the Corporation upon the exercise of such Options or the conversion or exchange of such Convertible Securities, in the case of Options for Convertible Securities or Series B Redeemable Preferred Stock, the exercise of such Options for Convertible Securities or Series B Redeemable Preferred Stock and the conversion or exchange of such Convertible Securities or Series B Redeemable Preferred Stock by

 

	
  

	
(B)

	
the maximum number of shares of Common Stock (as set forth in the instruments relating thereto, without regard to any provision contained therein designed to protect against the dilution) issuable upon the exercise of such Options or conversion or exchange of such Convertible Securities.

 

	 	
(d) 

	
Adjustments to Series B Conversion Price for Stock Dividends and for Combinations or Subdivision of Common Stock. In the event that the Corporation at any time or from time to time after the Original Issue Date shall declare or pay, without consideration, any dividend on the Common Stock payable in Common Stock or in any right to acquire Common Stock for no consideration, or shall effect a subdivision of the outstanding shares of Common Stock into a greater number of shares of Common Stock (by stock split, reclassification or otherwise than by payment of a dividend in Common Stock or in any right to acquire Common Stock), or in the event the outstanding shares of Common Stock shall be combined or consolidated, by reclassification or otherwise, into a lesser number of shares of Common Stock, then the Series B Conversion Price in effect immediately prior to such event shall, concurrently with the effectiveness of such event, be proportionately decreased or increased, as appropriate. In the event that the Corporation shall declare or pay, without consideration, any dividend on the Common Stock payable in any right to acquire Common Stock for no consideration, then the Corporation shall be deemed to have made a dividend payable in Common Stock in an amount of shares equal to the maximum number of shares issuable upon exercise of such rights to acquire Common Stock.

  

8

  

 

	 	
(e)

	
Adjustments for Reclassification and Reorganization. If the Common Stock issuable upon conversion of the Series B Redeemable Preferred Stock shall be changed into the same or a different number of shares of any other class or classes of stock, whether by capital reorganization, reclassification or otherwise (other than a subdivision or combination of shares provided for in Section G.(d) above or a merger or other reorganization referred to in Section D.(c) above), the Series B Conversion Price therein effect shall, concurrently with the effectiveness of such reorganization or reclassification, be proportionately adjusted so that the Series B Redeemable Preferred Stock shall be convertible into, in lieu of the number of shares of Common Stock which the holders would otherwise have been entitled to receive, a number of shares of such other class or classes of stock equivalent to the number of shares of Common stock that would have been subject to receipt by the holders upon conversion of the Series B Redeemable Preferred Stock immediately before that change.

 

	 	
(f)

	
No Impairment. The Corporation will not, by amendment of its Certificate of Incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms to be observed or performed hereunder by the Corporation, but will at all times in good faith assist in the carrying out of all the provisions of this Section 5 and in the taking of all such action as may be necessary or appropriate in order to protect the Conversion Rights of the holders of the Series B Redeemable Preferred Stock against impairment.

 

	 	
(g)

	
Certificates as to Adjustments. Upon the occurrence of each adjustment or readjustment of any Series B Conversion Price pursuant to this Section G, the Corporation at its expense shall promptly compute such adjustment or readjustment in accordance with the terms hereof and prepare and furnish to each holder of Series B Redeemable Preferred Stock a certificate executed by the Corporation’s President or Chief Financial Officer setting forth such adjustment or readjustment and showing in detail the facts upon which such adjustment or readjustment is based. The Corporation shall, upon the written request at any time of any holder of Series B Redeemable Preferred Stock, furnish or cause to be furnished to such holder a like certificate setting forth (i) such adjustments and readjustments, (ii) the Series B Conversion Price for such series of Preferred Stock at the time in effect, and (iii) the number of shares of Common Stock and the amount, if any, of other property which at the time would be received upon the conversion of the Series B Redeemable Preferred Stock.

 

	 	
(Ii)

	
Notices of Record Date.In the event that the Corporation shall propose at any time: (i) to declare any dividend or distribution upon its Common Stock, whether in cash, property, stock or other securities, whether or not a regular cash dividend and whether or not out of earnings or earned surplus; (ii) to offer for subscription pro rata to the holders of any class or series of its stock any additional shares of stock of any class or series or other rights; (iii) to effect any reclassification or recapitalization of its Common Stock outstanding involving a change in the Common Stock; or (iv) to merge or consolidate with or into any other corporation, or sell, lease or convey all or substantially all of its assets, or to liquidate, dissolve or wind up; then, in connection with each such event, the Corporation shall send to the holders of the Series B Redeemable Preferred Stock:

  

9

  

 

	
  

	
(1)

	
at least 20 days’ prior written notice of the date on which a record shall be taken for such dividend, distribution or subscription rights (and specifying the date on which the holders of Common Stock shall be entitled thereto) or for determining rights to vote, if any, in respect of the matters referred to in (iii) and (iv) above; and

 

	
  

	
(2)

	
in the case of the matters referred to in (iii) and (iv) above, at least 20 days’ prior written notice of the date when the same shall take place (and specifying the date on which the holders of Common Stock shall be entitled to exchange their Common Stock for securities or other property deliverable upon the occurrence of such event).

 

	
  

	
(i)

	
Issue Taxes. The Corporation shall pay any and all issue and other taxes that my be payable in respect of any issue or delivery of shares of Common Stock on conversion of Series B Redeemable Preferred Stock pursuant hereto; provided; however, that the Corporation shall not be obligated to pay any transfer taxes resulting from any transfer requested by any holder in connection with any such conversion.

 

	
  

	
(j)

	
Reservation of Stock Issuable Upon Conversion. The Corporation shall at all times reserve and keep available out if its authorized but unissued shares of Common Stock, solely for the purpose of effecting the conversion of the shares of the Series B Redeemable Preferred Stock, such number of its shares of Common Stock as shall from time to time be sufficient to effect the conversion of all outstanding shares of the Series B Redeemable Preferred Stock; and if at any time the number of authorized but unissued shares of Common Stock shall not be sufficient to effect the conversion of all then outstanding shares of the Series B Redeemable Preferred Stock, the Corporation will take such corporate action as may, in the opinion of its counsel, be necessary to increase its authorized but unissued shares of Common Stock to such number of shares as shall be sufficient for such purpose, including, without limitation, engaging in best efforts to obtain the requisite stockholder approval of any necessary amendment to the Certificate of Incorporation.

 

	
  

	
(k)

	
Fractional Shares. No fractional share shall be issued upon the conversion of any share or shares of Series B Redeemable Preferred Stock. All shares of Common Stock (including fractions thereof) issuable upon conversion of more than one share of Series B Redeemable Preferred Stock by a holder thereof shall be aggregated for purposes of determining whether the conversion would result in the issuance of any fractional shares. If, after the aforementioned aggregation, the conversion would result in the issuance of a fraction of a share of Common Stock the Corporation shall, in lieu of issuing any fractional share, pay the holder otherwise entitled to such fraction a sum in cash equal to the fair market value of such fraction on the date of conversion (as determined in good faith by the Board of Directors).

 

	
  

	
(l)

	
Notices. Any notice required by the provisions of this Section G to be given to the holders of shares of Series B Redeemable Preferred Stock shall be deemed given if deposited in the United States mail, postage prepaid, or if sent by facsimile or delivered personally by hand or nationally recognized courier and addressed to each holder of record at such holder’s address or facsimile number appearing in the records of the Corporation.

 

	
H.

	
Restrictions and Limitations. So long as any shares of Series B Convertible Convertible Preferres remain outtanding, the Corporation shall not (by amendment, merger, consilidation, or otherwise), without the vote or written consent of the holders of at least 66% of the then outstanding shares of the Series B Redeemable Preferred Stock, voting together a a single class: (i) authorize or issue, or obligate itself to issue, any other equity security (including any security convertible into or exercisable for any equity security) senior to or on a parity with the Series B Redeemable Preferred Stock as to dividend rights or redemption rights or liquidation preferences; or (ii) amend its Certificate of Incorporation or Bylaws w if such amendment would change any of the rights, preferences or privileges provided for herein. Without limiting the generality of the foregoing, the Corporation will not amend its Certificate of Incorporation or Bylaws (or take any action by merger, consolidation or otherwise) without the approval of the holders of 66% of the then outstanding shres of the Series B Redeemable Preferred Stock.

 

 

 

 

 

 

 

 10

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00229-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00229-of-00352.parquet"}]]